The MLL gene located at 11q23 has been described as a 'promiscuous' gene due its involvement with a large number of genetic partners. The EU Concerted Action Workshop on 11q23 provided 550 cases for study of which 82 showed abnormalities which did not involve the established translocations or deletion of 11q23. In these 'other' cases, which included inversions and duplications, 11q23 was found to be involved with 25 chromosome partners of which 10 had not been previously reported. These were 1q31, 4p11, 6q13, 8q21, 10q22, 10q25, 11q11, 11q21, 13q34 and 18q23. This study demonstrated the value of the Workshop, in confirming the diversity of chromosomal partner sites involved with 11q23 and in the identification of new partners.
Introduction
A variety of recurrent chromosomal rearrangements involving chromosome band 11q23 have been reported in the hematological malignancies. More than 25 chromosome bands have been implicated as partner sites with 11q23. 1 Although the majority of 11q23 rearrangements have been shown to involve the MLL gene, limited information is available on the MLL status of many of the cases reported to have 11q23 involvement from cytogenetic studies.
The EU Concerted Action Workshop on 11q23 provided an ideal opportunity to search for new chromosomal partner sites. This paper examines cases submitted to the Workshop which showed neither one of the well characterised chromosome associations with 11q23, namely, t(4;11), t(6;11), t(9;11), t(10;11), t(11;19) nor del(11)(q23). The cases in this study have been compared with other cases reported in the literature and 10 new chromosomal bands involved in rearrangements with 11q23 have been identified.
Patients
Of the 550 cases submitted to the EU Concerted Action Workshop on 11q23, 82 cases were classified into the group described as 'other'. This group included all cases with abnormalities of 11q23, identified by cytogenetic analysis of Gbanded or R-banded preparations, which had not been classified into one of the commonly occurring abnormality groups. Deletions involving 11q23 and the following translocations were excluded: t(4;11)(q21;q23), t(6;11)(q27;q23), t(9;11)(p21ෂ22;q23), t(11;19)(q23;p13), t(10;11)(p12;q23).
The 'other' group also included duplications of 11q23 [dup(11)(q23)], inversions of chromosome 11involving 11q23 [inv (11) ], and cases with unidentified additional chromosomal material at 11q23 [add(11)(q23)].
Limited studies by fluorescence in situ hybridization (FISH) had been carried out on the cases in this group. The results of these FISH studies using probes which span the MLL gene, for example, MLL cosmid contig probes or the YAC, 13HH4, to demonstrate MLL involvement have been recorded. In some cases the results of Southern analysis were available.
Results and discussion

A. Overall cases in 'other' group
Within the 'other' group the majority (52) of the 82 patients were diagnosed as acute myeloid leukemia (AML). Most of these (18 patients) were classified as AML M4, others were M5a (six patients) and M5b (nine patients). The remaining cases were distributed throughout the other FAB groups, with the exception of AML M3 and M7. Eighteen patients were diagnosed with acute lymphoblastic leukemia (ALL), immunophenotyping was available in 15 cases; pro-B (nine cases), T-ALL (four cases), pre-B (one case) and otherwise unclassified B-lineage (one case). Nine patients had myelodysplasia (MDS) including FAB types RA (three cases) and RAEB (three cases). Three cases were unclassified. There was one case each of myeloproliferative disease (MPD) and acute leukaemia, unclassified. There were 44 males and 38 females. Patients were aged Ͻ1 year (10 cases), 1-9 years (20 cases), 10-14 years (six cases), 15-39 years (18 cases), 40-49 years (12 cases) and Ͼ50 years (15 cases).
The chromosomal abnormalities have been sub-divided into translocations, insertions, duplications, inversions and those with additional unidentified material on 11q23. The cases are grouped according to chromosomal breakpoint. Associations between karyotypes, clinical and follow-up data are shown in Table 1 . FISH and/or molecular studies had been carried out in 30 cases, producing conclusive evidence for the involvement of MLL in 23 cases (Table 1) . Details of the cases presented to the Workshop were compared with published cases as shown in Table 2 . The Workshop reported 10 novel chromosomal partner sites involved in rearrangements with 11q23, which are starred in Table 1 some 1 and 11q23 involving two breakpoints which had been previously reported. Seven cases involved the short arm band 1p32 and the remaining seven cases the long arm, 1q21.
(i) t(1;11)(p32;q23): The first seven cases in Table 1 (cases  163,  2 172,  2 186 , 322, 411, 490 and 560) showed the translocation, t(1;11)(p32;q23). All seven of the patients were females. In six of the seven this translocation was the sole abnormality and one case (490) showed a subclone with trisomy 8. In only two of the cases had FISH (case 490) or molecular studies (case 560) been carried out, in which a rearrangement of the MLL gene was demonstrated.
Five of the seven patients were infants, three had ALL of L1 or L2 morphology and pro-B immunophenotype (cases 163, 186 and 560), and two were AML, one of FAB type M0 (case 172) and one M5a (case 490). The two remaining patients were adults with AML, one of 67 years with AML M4 (case 322) and the other of 26 years with AML M5a (cases 411). This patient was identified as secondary leukemia. All seven patients achieved a complete remission. Three of the infant cases relapsed and died (163, 172, 560). Two of the four surviving members of this group had been given bone marrow transplants (cases 186, 411).
This translocation has been previously reported in 14 cases in the literature, in acute biphenotypic leukemia (AL bi) as the sole karyotypic change, 3 in ALL as a sole abnormality [4] [5] [6] [7] or as part of a complex karyotype, 8, 9 in AML M1 as a sole abnormality 10 or as a secondary karyotypic change. 11 It has also been found in AML M4 12 and AML M5 3 as part of a simple karyotype and in a case of MDS RA as a sole abnormality. 13 Two variant translocations involving 1p32 and the short arm of chromosome lymphoid 4, t(1;11;4)(p32;q13q23;p16), in AML M5, 14 and the long arm of chromosome 6, t(1;6;11)(p32;q21;q23) in a case of T cell chronic lymphoblastic leukemia (CLL) 15 have been reported. The gene partner of MLL located at 1p32, AF1p, has been described. 3 (ii) t(1;11)(q21; 16 and 391). These cases with the der(11) all showed additional chromosomal abnormalities and the karyotype of case 391 was highly complex. Cases 183, 363 and 377 were described as secondary disease. The four patients with this unbalanced form of the karyotype were the only members of this group to have relapsed and died of the disease, and included the only case to have had a bone marrow transplant following transformation to AML (case 183). In these cases survival was extremely short. Two reported cases with der(11), as an unbalanced form of the translocation, were diagnosed as ALL with short survival, 17, 18 one further case of AL bi showed the der(11) as part of a complex karyotype. 19 The three cases with the balanced translocation (cases 229, 432 and 473) showed this as the sole abnormality, apart from a sub-clone with an additional chromosome ?22 in case 432. The balanced translocation has previously been reported to be preferentially associated with AML M4. Seven reported cases showed this translocation either as the sole abnormality or as part of a simple karyotype in six cases of AML M4 [20] [21] [22] [23] [24] and one case of AML M5. 25 The MLL partner gene at 1q21 (AF1q) has been characterised. 26 2. Abnormalities of chromosome 2: t(2;11)(p21;q23): Three cases showed t(2;11)(p21;q23) (cases 345, 511 and 583). One case of AML showed this translocation as the sole abnormality (case 511) and the other two cases of MDS showed a deletion of the long arm of chromosome 5 as an additional abnormality in all cells examined (cases 345 and 583). The clinical features of these two female cases of 41 and 46 years with RA were suggestive of the 5q− syndrome. Although case 345 died shortly after transformation to AML M5a, case 583 remained alive with no evidence of transformation at more than 6 years. In the Workshop, two cases of RAEB and one case of RAEBt were found with a deletion of 5q in association with a deletion of 11q23 as the only other abnormality (cases 140, 134, 582, as described in Harbott et al 27 ). A case with del(5q) was found in this patient series with t(11;21)(q2?3;q11) (case 274). Five other cases showed del(5q) in association with abnormalities involving 11q23, but these were cases of AML, RA and RAEB with highly complex karyotypes (cases 125, 131, 368, 384 and 462). In a search of the literature 10 cases were found with t(2;11)(p21;q23). All except one were AML or MDS. [28] [29] [30] [31] [32] [33] The remaining one was an ALL. 34 In four of the six cases of MDS RA, the translocation was found in association with del(5q). [30] [31] [32] [33] These findings, therefore, suggest that this abnormality may be preferentially associated with deletion of 5q− in cases with the clinical characteristics of 5q− syndrome. The single case of ALL, also, showed a deletion of 5q as a secondary change as part of a complex evolving karyotype. 34 
Abnormalities of chromosome 3:
Rearrangements involving chromosome bands 3p13ෂ21: The only abnormalities of chromosome 3 found in this study were two cases in which the short arm was involved. One case involved 3p13 in a translocation with 11q23, t(3;11)(p13;q23) (case 602), in which the derived chromosome 11 was present as part of a highly complex karyotype. FISH analysis with whole chromosome 'painting' (wcp) confirmed the origin of the der(11) as a t(3;11) but MLL involvement was not tested for. This patient did not achieve complete remission and died less than 1 year from diagnosis. The second case showed an insertion of chromosome 11 material into the short arm of chromosome 3 at the breakpoint 3p21, ins(3;11)(p21;q13q23), as the sole abnormality in this karyotype (case 104). Interphase FISH studies using the YAC, 13HH4, showed the signal to be split in the abnormal cells, indicating the rearrangement of MLL. This case was of secondary disease and the patient relapsed and died just over 1 year from diagnosis. Five cases were found in the literature involving chromosome bands 3p12ෂ21 in translocation with 11q23. One case was of ALL showing the balanced translocation as part of a complex karyotype. 35 The remaining four reported cases showed the derived chromosome 11 as the unbalanced form of the translocation in association with other abnormalities, B-ALL (one case), 36 MDS (two cases) 37, 38 and multiple myeloma (MM) (1 case). 39 4. Abnormalities of chromosome 5: t(5;11)(q31;q23): Two cases in the Workshop had a translocation involving 11q23 with 5q31, t(5;11)(q31;q23). In one case of infant ALL with a pro-B immunophenotype this was associated with trisomy 8 in all cells examined (case 36). 40 MLL involvement was confirmed by FISH using the YAC, 13HH4. The second case was diagnosed as Philadelphia negative chronic myeloid leukemia (CML) in which this was the sole chromosome abnormality (case 234). Two further cases have been published with this translocation as part of a simple karyotype. One was an ALL 41 and the second was AML M1. 42 A new MLL fusion partner and potential myeloid tumour suppressor gene has been identified in a case with t(5;11)(q31;q23). 43 5. Abnormalities of chromosome 11: t(11;11)(q13;q23): A 13-year-old female with AML M5b as a secondary leukemia was shown to have a translocation, t(11;11)(q13;q23), as the sole karyotypic change (case 502). 44 Rearrangement of the MLL gene was found by Southern analysis. This patient relapsed and died within 1 year of diagnosis. Two cases were found in the literature with the same translocation as the sole abnormality. One was an AML M4 45 and one an AML M5b which arose as a therapy-related leukaemia in a child previously treated with the etoposide,VP16, 44 as in this case.
6. Abnormalities of chromosome 12: t(11;12)(q23;q13): This translocation, t(11;12)(q23;q13), was found as part of a complex karyotype in association with t(8;14)(q32;q24) (case 43). The diagnosis was one of ALL L3 with a pro-B immunophenotype in a 48-year-old male. Although complete remission was achieved he relapsed and died within 2 months of diagnosis. The poor prognosis is likely to be associated with the diagnosis in this patient. Two further cases were reported in the literature with t(11;12)(q23;q13). One was part of a complex karyotype in CLL 46 and the other was an unbalanced der(11) as part of a complex karyotypic picture in RAEBt. 47 7. Abnormalities of chromosome 15: t(11;15)(q23;q14ෂ15): Two cases were found with translocations involving 15q14ෂ15 and 11q23. Case 358 had t(11;15)(q23;q14) 16 and Southern analysis confirmed a rearrangement of MLL. Case 623 was described as t(11;15)(q23;q15). In both cases the translocation was associated with an abnormality of chromosome 3. Although both were AML M4, the adult patient (358) died 3.5 months after diagnosis, whereas the child (case 623) was alive in complete remission at 6.5 years following a bone marrow transplant. Five previously reported cases, two cases of ALL, 48, 49 one of AML M1 50 and two of AML M2, 50 were found to have this translocation in association with other chromosome abnormalities. In these three cases of AML the clinical course of the disease was aggressive and the survival was short. One case of T-ALL showed this rearrangement as the sole abnormality. 51 In this case a novel MLL partner gene was identified, AF-15.
Abnormalities of chromosome 17:
(i) t(11;17)(q23;p13): A single case was presented involving the short arm of chromosome 17 in a translocation with 11q23, t(11;17)(q23;p13), in association with a trisomy 22 (case 539). 52 FISH studies with the MLL cosmid contig (Oncor, Gaithersburg, MD, USA) demonstrated the involvement of MLL although it is, as yet, unknown whether TP53 was involved in this case. This infant was diagnosed as ALL L1/L2 with a pro-B immunophenotype. He remained in complete remission at 8.5 months. Two cases of AL bi reported in the literature showed this translocation as the sole abnormality. 53, 54 Another case of transforming MDS showed the change as a der(11) in a complex karyotype 55 and one variant translocation has been described, t(9;17;11)(p21;p13;q23), as part of a complex karyotype in AML M5b. 56 (ii) t(11;17)(q23;q12ෂ21): One case in the Workshop was described as t(11;17)(q23;q12) (case 376) and six cases as t(11;17)(q23;q21) (cases 184, 337, 356, 16 398, 456 and 516). In all cases except two (337 and 356) the translocation was found as the sole karyotypic change. In case 337 only two additional chromosomal changes were present involving chromosome 13 and a marker and in case 356 the translocation was associated with monosomy 7. 16 Cases 337, 376 and 516 showed evidence of karyotypic evolution. FISH analysis confirmed the involvement of MLL in case 516. Southern analysis in case 337 was unable to confirm the presence of a MLL rearrangement.
All in this group, except one case (456), were diagnosed as AML M4 (cases 184 and 516) M5a (case 337) or M5b (case 376). 16 No cases of AML M3 were found. Case 456 was described as a T cell ALL in an adult of FAB type L1/L2. In case 398, no diagnosis was given. All patients relapsed and died between 12 days and 19.5 months, including the three cases known to have had a bone marrow transplant (cases 337, 456 and 516). Case 184 was the only childhood case in this group and had the longest survival. In the literature, 16 cases were reported with this translocation, three cases of ALL [57] [58] [59] and 13 of AML, five of which were AML M3. 60, 61 Three cases were reported as AML M2, [61] [62] [63] two cases as AML M4 64, 65 and three cases as AML M5. [66] [67] [68] The partner gene at 17q21 has been characterised as AF17. In the AML M3 cases it is likely that the retinoic acid alpha receptor gene (RARA) at 17q21 is involved with PLZF, which is a gene coding for a zinc finger protein located in 11q23. 69 (iii) t(11;17)(q23;q23ෂ25): One case of AML M1 was described with t(11;17)(q23;q23) as the sole abnormality (case 508). 70 MLL rearrangement was confirmed by Southern analysis. Four cases in the literature were found to have t(11;17)(q23;q23) as the sole karyotypic change.
Two of these cases were AML M2 61, 63 and two were AML M5. 21, 71 Five other cases in this study had the translocation t(11;17)(q23;q25) (cases 531, 551, 557, 610 and 622). In three of these cases it was the sole karyotypic change in the stem line (cases 531, 551 and 610), although case 551 showed karyotypic evolution in a side line. Case 557 showed trisomy 10 in association with the translocation. In case 622 the translocation was found as the only structural change in a hyperdiploid karyotype. MLL was shown by Southern analysis to be rearranged in this case, although reverse transcriptase polymerase chain reaction (RT-PCR) did not confirm the presence of the MLL/AF17 transcript. This was verified by FISH with the MLL cosmid contig. The derived chromosome 17 showed the presence of a MLL signal. No MLL signal was present on the derived chromosome 11. The same molecular and FISH results were found in case 610. In cases 508 and 551, Southern analysis confirmed that MLL was rearranged. Case 557 showed MLL to be rearranged from FISH studies.
Case 531 was a 14-year-old with pro-B ALL. He relapsed and died 15.5 months following diagnosis, although he had been given a bone marrow transplant. The other cases in this group were AML M1 (cases 508 and 557) or M4 (cases 551, 610 and 622). Cases 610 and 622 were children. Apart from case 610 all patients in this group had relapsed and died between 22 days and 38.5 months, including two, in addition to case 531, who had received a bone marrow transplant (cases 557 and 622). One case involving 17q24 in association with 11q23 as a sole abnormality was described in the literature in a case of AML M1. 72 The translocation involving 17q25, t(11;17)(q23;q25), as a sole chromosomal abnormality or as part of a simple karyotype has been previously reported in two cases of ALL, 73, 74 83, 84 and one case of chronic myelomonocytic leukemia (CMML). 85 A complex karyotype was found with a variant translocation t(3;17;11)(p23;q25;q13q23), in a case of MDS. 86 9. Abnormalities of chromosome 21: t(11;21)(q23;q11): This translocation, t(11;21)(q23;q11), was found in a single case (case 274). Due to the similarities in the banding pattern of 11qter and 21qter the precise breakpoint on chromosome 11 was uncertain. Molecular or FISH studies are required to determine the involvement of MLL. A second copy of the der(11) replaced the normal 11 in the five cells analysed. The abnormality was found in association with a del(5q). Although diagnosed as MDS RA the patient died within 4 months of diagnosis without evidence of transformation. There is one other report of 21q11 involved with 11q23 in the literature, reviewed in Bernard and Berger. 1 
Abnormalities of chromosome X:
Translocations involving 11q23 and the long arm of the X chromosome, Xq13ෂ24: Three cases were found with translocations involving the long arm of the X chromosome and 11q23. The translocations were described as t(X;11)(q13;q23) (case 314), t(X;11)(q22;q23) (case 109) and t(X;11)(q24;q23) (case 160). 2 In each case this abnormality was the sole karyotypic change. All patients were males aged 1 (cases 314 and 160) and 3 (case 109) years with AML M2 (case 109), M4 (case 314) or M5 (case 160) FAB type. Case 314 died at 24.5 months. The other two patients remained alive in complete remission at 97 months (case 109) and 101.5 months (case 160). In the literature, one case of AML M2 62 and two cases of AML M4 65, 87 have been described with t(X;11)(q13;q23) as the sole karyotypic change. This translocation has also been found in a case of CLL. 46 The partner gene of MLL at Xq13 has been characterised. 88 Two cases have been previously reported in which Xq22 is involved with 11q23. One case of AML M7 showed t(X;11)(q22;q23) as part of a complex karyotype. 89 In the second case of AML the breakpoint was involved in a highly complex change, der(X)t(X;11)(q22;q23) ins(X;11)(q22;p13p15).
(c) Chromosome inversions
Inversions involving 11q23 and the p arm, p14ෂ15: Five cases were found in the Workshop with the pericentric inversion, inv(11)(p14q23) (cases 131 and 351 16 ) or inv(11)(p15q23) (cases 120, 289 and 596). In the three latter cases this was found as the sole karyotypic abnormality, although cases 289 and 596 had a population of cells with trisomy 8 as a secondary change. Two of these cases showed no evidence of involvement of the MLL gene by FISH with the cosmid contig probe (case 120) or Southern analysis (case 289). In case 351 the inv(11) was found in association with monosomy 7 and in the remaining case, 131, the inv(11) was part of a highly complex karyotype in which MLL involvement was demonstrated by FISH. All cases were myeloid disorders, including three cases of MDS (cases 131, 289 and 596) and two of AML M4 (cases 120 and 351). Case 120 was the only child in this group. The two cases of secondary disease (cases 289 and 351) died within 1 year. Five cases in the literature have been described with inversion of chromosome 11 involving p14ෂ15 with 11q23. These were two cases of ALL, one case with inv(11) as the sole karyotypic change 91 and in the second case as part of a complex karyotype, 92 one case of AML M2 in which other chromosome abnormalities were present, 93 one of CMML 94 and one case of CML. 95 One case of AML M6 was reported with a complex rearrangement of chromosome 11 in addition to the inversion, der(11)inv(11)(p15q23) del(11)(p12p13). 96 One translocation t(11;11)(p15;q23) has been previously described in a case of AML M5 97 and one ring 11, r(11)(p15q23), in a case of AML M6 with a complex karyotype.
(d) Duplications
Duplications involving 11q23: Five cases were found with a duplication of chromosome 11 which involved 11q23. Two 
Figure 2
A metaphase from case 518 showing the translocation, t(6;11)(q13;q23). The two chromosomes 11 are identified by the centromeric probe (green signals). The MLL signal at 11q23 is red. The signal is split between the derived chromosomes 6 (open arrow) and 11 (solid arrow). A single MLL signal is shown on the normal chromosome 11. This figure was kindly provided by Mrs S Swanton, Royal Free Hospital, London.
of the cases described as dup(11)(q23q23) showed duplication of MLL by FISH (cases 125 and 484). Case 125 is shown in Figure 1 . Two cases were dup(11)(q14q23) (cases 462 and 464 99 ) and one was described as dup(11)(q23q24) (case 380) 16 which showed no rearrangement of MLL by Southern analysis. In two of the cases the dup(11) formed part of a highly complex karyotype (cases 125 and 462) in association with a deletion of the long arm of chromosome 5. In one case dup(11) was the sole karyotypic change (case 484). In case 464 it occurred with pentasomy 8 and in case 380 it was found with monosomy 10, both of which are rare findings. All cases were adults with AML apart from the one case of MDS RA with the highly complex karyotype. All patients died within 1 year. Duplication of 11q23 has previously been reported in two cases of ALL 100, 101 and one case of AML M1 102 as part of a complex karyotype. One case of adult T cell leukemia/lymphoma (ATLL) had a duplicated region described as dup(11)(q13q23) 103 and a case of AML showed a duplicated 11, as part of a complex rearrangement, der(11)dup(11)(q13q23)t(11;15)(q25;q12). 104 In one case of AML M5 with a complex karyotype an homogeneously staining region was described at 11q23. 105 Duplications of exons 2-6, the exons involved in the critical region of the fused MLL partner transcript, have been described in AML.
(e) Unidentified material at 11q23
Eighteen cases were assigned to this group due to the presence of unidentified chromosomal material on 11q23, add(11)(q23) ( Table 1 ). In four cases this was the sole abnormality identified, indicating the presence of an unbalanced rearrangement (cases 115, 167, 2 215 and 617). Apart from one previously published case with an additional X chromosome as the only other change (case 168), 2 all the remaining cases showed other unidentified chromosomal regions within the karyotype. Therefore, it could not be decided whether the add(11) formed part of a balanced rearrangement or not. One case by interphase FISH (case 496) and two cases from Southern analysis (cases 338 and 482) showed rearrangement of MLL. The cases comprised adults and children, ALL, AML and one case of MDS RAEB (case 368). 16 The group showed variation in survival, although six patients remained alive at more than 3 years (cases 53, 167, 168, 170, 2 338 and 617). Further FISH and molecular studies are planned for these cases in an attempt to find other new partner chromosome sites involved with MLL.
Forty-three cases of add(11)(q23) were reported in the literature, from a search of Mitelman's Catolog of Chromosome Aberrations in Cancer. 107 These included 12 cases of ALL, 14 cases of AML, MDS, CMML, ATLL, MM and Sezary syndrome. Apart from one case of RARS and one case of AML M5, all were found in association with a complex karyotype. Since limited information is available on MLL status from either FISH or molecular studies, little value can be attributed to these cases until further investigations have been carried out in an attempt to identify the additional material.
C. Novel 11q23 partners (i) der(11)t(1;11)(q31;q23): A single case was described involving an alternative breakpoint on the long arm of chromosome 1 at q31 in a translocation with 11q23 (case 393). In this case, an adult with AML M5b it was unclear from the FISH result whether MLL was involved since the der(1) chromosome was not present. There were no cases reported in the literature with a 1q31 breakpoint associated with 11q23. Two cases were reported with translocations involving 1q32. One showed t(1;11)(q32;q23) as a secondary change in a case of AML M2, 108 and the second showed this translocation as an unbalanced derived chromosome 11 as part of a complex karyotype in a case of RAEBt.
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(ii) t(4;11)(p11;q23): A single case was found with a translocation involving the short arm of chromosome 4, t(4;11)(p11;q23), as the sole karyotypic abnormality (case 607). This 68-year-old female with AML M5b had secondary disease. She relapsed and died within 11 months of diagnosis, without entering remission. No cases were found in the literature with the involvement of the short arm of chromosome 4 and 11q23. (iii) t(6;11)(q13;q23): A single case was described with, t(6;11)(q13;q23) (case 518). 52 In this 14-year-old female with AML M4 this was the sole chromosome abnormality. FISH studies with the MLL cosmid contig (Oncor) confirmed the involvement of MLL in this case (Figure 2) . Although she achieved a complete remission she relapsed and died within 2 years of diagnosis in spite of having a bone marrow transplant. There was no other report in the literature of 6q13 in association with 11q23. However, since the breakpoints on 6q are difficult to define precisely by banding analysis it was noted that there are reports of t(6;11)(q15;q23) in two cases of AML M0 109, 110 as simple abnormalities, with a deletion of 5q. One case has been reported which involves 6q21, t(6;11)(q21;q23).
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(iv) t(8;11)(q21;q23): Another single case was found with a t(8;11)(q21;q23) (case 200). A subclone was present in which a deletion of the short arm of chromosome 2 was suspected in association with trisomy 4. This 14-year-old male, diagnosed as acute leukemia, remained alive in second remission, following a bone marrow transplant, at almost 3 years. This is the only reported case of the involvement of chromosome 8 with 11q23. (v) The long arm of chromosome 10: Three cases were observed with translocations of the long arm of chromosome 10 with 11q23. Involvement of the long arm of chromosome 10 has not been previously reported in association with 11q23. (See note added in proof.) t(10;11)(q22;q23): Additional abnormalities were found in association with the t(10;11)(q22;q23) in two cases with this translocation (cases 369 and 580). In case 369 the derived chromosome 10 was missing. Both patients were adults with AML M5, M5a (case 580) and M5b (case 369). Both achieved complete remission but died of the disease within 1 year of diagnosis. t(10;11)(q25;q23): A 24-year-old male with AML M5b (case 640) had the translocation, t(10;11)(q25;q23 The cases in this study were compared with previously reported cases ( Table 2 ). In addition, the review of Bernard and Berger 1 revealed a series of chromosomal breakpoints which were not found in this study. These were 1q32, 2q37, 8q11, 9q33, 12p13, 14q11, 14q32, 17q11, 18q12, 20q13 and 22q12.
From a review of Mitelman's catalog, 107 a series of breakpoints were identified which had not been found in the Workshop nor reviewed by Bernard and Berger.
1 These were 1p36, 1p34, 1p31, 1p22, 1p13, 1q10, 1q12, 1q22, 1q23, 1q42, 2p25, 2p10, 3p25, 3p11, 3q21, 3q22, 3q23, 3q27, 5q12, 5q13, 5q14, 7p15, 7p22, 7q11, 7q22, 11p13, 11p11, 11q22, 11q25, 12p12, 12q22, 12q24, 13q14, 14q24, 15q21, 15q24, 16p13, 16q24, 17q12, 17q22, 17q27, 18q21, 21q21, 21q22, 22q11 and Xq25.
This study has substantially increased the number of cases within certain patient groups with previously reported chromosomal partner sites involved with 11q23, for example, 1p32 and 1q21. Where small numbers of cases with the same breakpoint had been previously identified the finding of further cases has significantly increased these numbers and, thus, increased the potential for finding new gene partners at these sites. This applies to 5q31, 3p13ෂ21, 11p14ෂ5, 11q13, 12q13, 15q14ෂ15, 17p13, 21q11 and Xq22.
Three more cases involving 2p21 have been added to the 10 previously published cases. We have identified a strong association of this abnormality with the deletion of the long arm of chromosome 5.
This study has revealed 10 novel chromosome partner sites, 1q31, 4p11, 6q13, 8q21, 10q22, 10q25, 11q11, 11q21, 13q34 and 18q23. Apart from the two cases involving 10q22, these sites were found in a single case only. MLL rearrangement was confirmed in only three of these cases, the 6q13 case by FISH and the 10q25 and 11q13 cases by Southern analysis. The remaining seven cases need to be evaluated for MLL involvement prior to the pursuit of detailed molecular investigations to identify the partner genes involved. This study has demonstrated the value of such a Workshop in confirming the diversity of chromosome partner sites involved with 11q23 and in the identification of new partners. Further cases with these new abnormalities need to be searched for in addition to a continuing search for more new partners.
Note added in proof
Partial karyotypes in a paper by Thirman et al (New Engl J Med 1993; 329: 909-914) identified an additional 11q23 chromosomal partner site, 10p11, in a case of AML M4 which had not been previously reported. This paper also identified the chromosomal band 10q22 as a partner with 11q23 from a partial karyotype with a t(10;11)(q22;q23). Therefore the two cases described in this study wtih 10q22 as a novel chromosomal partner site should be increased to three.
